Condition: Immediate Post-Treatment Care · Aging Mid-Face · Aging · Sponsor: Lynch Regenerative Medicine
ariessence is intended to be used as a viscous, leave-on solution designed for topical application to the face. It is intended to be used following non-medical cosmetic procedures, performed by licensed healthcare professionals to enhance comfort and maintain skin hydration. This study is designed to be a multi-center, post-market cosmetic evaluation of ariessence applied to the full face after an ablative laser procedure to evaluate improvements in procedure tolerability and improvements in the appearance of the skin, compared to an emollient control.
This description comes directly from the study's public registry record.
Josh Arnold · 302-604-4532 · clinicaltrials@purity-health.com
Always discuss trial participation with your own doctor first.
| Laser & Skin Surgery Medical Group | Sacramento, California, United States | Recruiting |
| The Practice of Brian S. Biesman, MD | Nashville, Tennessee, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07718347